Conferences - Results from #60

ASTRO 2021: Focal Therapy as Alternative for Whole-Gland Therapy for Intermediate-Risk Prostate Cancer October 30, 2021

ASTRO 2021: Optimizing Hypofractionation: IMRT and SBRT October 30, 2021

ASTRO 2021: Conventional vs Hypofractionated Radiation for High Risk Prostate Cancer Patients (CHIRP): 24 months Patient Reported Quality of Life Outcomes of the Randomized Phase II CHIRP Trial October 30, 2021

ASTRO 2021: RTOG 0926: Phase II Protocol Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemo Following a Thorough Transurethral Surgical Re-Staging October 29, 2021

ASTRO 2021: Elective Nodal Irradiation with a Simultaneous Hypofractionated Integrated Prostate Boost for Localized High-Risk Prostate Cancer: Long-Term Results From a Prospective Clinical Trial October 29, 2021

ASTRO 2021: Detection Failure Patterns Using Advanced Imaging in Patients with Biochemical Recurrence Following Low Dose Rate Brachytherapy for Prostate Cancer October 29, 2021

ASTRO 2021: Molecular Imaging with Fluciclovine PET October 29, 2021

ASTRO 2021: Individual Patient Data Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium: Impact of ADT Use and Duration with Definitive Radiotherapy for Localized Prostate Cancer October 29, 2021

ASTRO 2021: Controversies in the Management of Muscle-Invasive Bladder Cancer October 29, 2021

ASTRO 2021: Current and Future Management Paradigms for Metastatic Castrate-Resistant Prostate Cancer October 29, 2021

ASTRO 2021: Newly Diagnosed Oligometastatic Prostate Cancer: Where Should We Focus the Beam? October 29, 2021

ASTRO 2021: Can We Cure Oligorecurrent Prostate Cancer? You May Be Surprised! October 28, 2021

ASTRO 2021: Is Metastasis-Directed Therapy the Wave of the Future in Oligo-mCRPC? October 28, 2021

ASTRO 2021: Systemic Therapy for Very High Risk to Oligometastatic Prostate Cancer October 27, 2021

ASTRO 2021: Radiation Therapy for Very High Risk to Oligometastatic Prostate Cancer October 27, 2021

ASTRO 2021: NCCN Guidelines for Radiation Therapy and Prostate Cancer: Updates and Controversies October 27, 2021

ANZUP Mini ASM 2021: Molecular Subtypes in MIBC – Moving Toward Better Patient Selection for Treatment October 19, 2021

ANZUP Mini ASM 2021: Evolving Treatment Landscape for Metastatic Urothelial Cancer October 19, 2021

ANZUP Mini ASM 2021: Convergence of Machine Learning and Genomics for Precision Cancer Medicine in Genitourinary Cancers and Beyond October 19, 2021

ANZUP Mini ASM 2021: Cross-Fire Debate: Waiting for Overall Survival Data: We May Wait October 18, 2021

Page 4 of 429

email news signup